In the sample of 295 French EGEA families with at least one asthmatic subject, a genome screen was conducted to identify potential linkage regions specific either to allergic rhinitis (AR) or to asthma as well as those shared by the two diseases. Two binary rhinitis phenotypes based on (1) diagnosis (AR bin1 ) and (2) symptoms (AR bin2 ) and a categorical ordered trait (AR cat ) were considered. Asthma phenotype was based on answers to a standardized questionnaire plus the presence of bronchial hyper-responsiveness. Linkage analyses were conducted using the maximum likelihood binomial (MLB) method. These analyses provided potential evidence for linkage to three regions in the whole sample: 1p31 for the phenotype defined by AR bin2 plus asthma (P ¼ 0.00016), 2q32 for AR bin2 (P ¼ 0.00016) and 3p24-p14 for AR cat (P ¼ 0.001). Two other regions were detected in the subset of 185 families with at most one asthmatic sib: 9p22 and 9q22-q34 for AR bin1 (P ¼ 0.001 and 0.0007, respectively). No region showed evidence for linkage to asthma without being also linked to AR. While 1p31 may contain a genetic determinant common to asthma and AR, 2q32, 3p24-p14, 9p22 and 9q22-q34 are more likely to harbor genetic factors specific to AR. Genes and Immunity (2005) 6, 95-102.
Introduction
Allergic rhinitis (AR) is clinically defined as a symptomatic disorder of the nose induced by an IgE-mediated inflammation of the nasal membranes. Although AR is not a severe disease, it alters the social life of patients and affects school performance and work productivity. 1 Asthma is a common respiratory disease characterized by variable airflow obstruction, inflammation of the airways and bronchial hyperresponsiveness (BHR). The presence of a genetic component for both AR and asthma has been well established by family studies 2 and twin studies. 3 Asthma and AR are common co-morbidities: most asthmatics have rhinitis and many patients with rhinitis suffer from asthma. 1 Familial association has been shown between AR and asthma. 4 AR may result from genetic determinants common to asthma, but there may be also genetic alterations specific to each of these phenotypes, as indicated by twin studies. 5, 6 As for asthma, AR is strongly associated with atopy, with most subjects having rhinitis being atopic, while only a part of atopic subjects suffer from rhinitis. Genetic determinants shared by asthma and AR are likely to result in part from the atopic component of these two diseases.
Many genome-wide searches and association studies have been conducted for asthma and atopy, measured by response to skin prick tests or IgE levels and for other related traits including eosinophil counts and bronchial responsiveness and have led to detect numerous linked regions. 7 The regions most often reported to be linked to asthma and/or associated phenotypes are 5q, 6p, 11p, 12q and 13q. These genome screens have led to identification of four genes by positional cloning: ADAM33 associated with asthma and BHR located on chromosome 20, 8 PHF11 associated with IgE levels and severe asthma on chromosome 13, 9 DPP10 associated with asthma on chromosome 2 10 and GPRA associated with high serum IgE or asthma on chromosome 7p. 11 In contrast, only two genome-wide searches 12, 13 have been recently conducted for AR that showed potential linkage to the following chromosomal regions: 4q24-q27 in a Danish sample of 33 families 12 and 1p36, 4q13 and 9q34 in a Japanese sample of 48 families. 13 No linkage region was common to these two studies and only the 1p36 region had been previously reported for asthma. 14 In a first genome-wide search in 107 French families of the EGEA study (Epidemiological study on the Genetics and Environment of Asthma) with at least two asthmatic siblings, 15 linkage analyses were conducted for asthma, IgE, skin test response, eosinophil counts and bronchial responsiveness using a panel of 254 microsatellites. A second genome scan was recently carried out for asthma/atopy-associated phenotypes in an extended sample of 295 EGEA families (having two sibs with DNA available and at least one asthmatic subject) and using a larger panel of 396 markers. 16 Using the same family sample and panel of markers of this second scan, the aim of the present study was to investigate the genetic factors specific either to AR or to asthma as well as those shared by AR and asthma. Three phenotypes were considered for AR: two binary phenotypes based on self-reporting (1) diagnosis (AR bin1 ) and (2) symptoms (AR bin2 ) according to a standardized questionnaire and a categorical ordered trait (AR cat ) based on a score computed from various items related to AR. 17 The asthma phenotype was based on answers to a questionnaire plus the presence of BHR. Linkage analyses were conducted using the maximum likelihood binomial (MLB) method, 18 developed for linkage analysis of binary and ordered categorical traits in sibships. Linkage analyses were first applied to the whole sample of 295 families (including 66, 86 and 110 sibships with at least two affected sibs for AR bin1 , AR bin2 and asthma, respectively, and 295 sibships informative for AR cat ). These analyses were also conducted for the three AR phenotypes, in a subsample of 185 families including at most one asthmatic sib.
This study represents the third published genome scan for AR applied to a larger sample than the two previous scans and the first genome-wide screen for both AR and asthma. These two diseases were analyzed separately and together (AR associated with asthma) to characterize the shared and unshared linked chromosomal regions by these two diseases.
Results

Distribution of AR and asthma
In the 726 genotyped siblings of the 295 EGEA families selected through one asthmatic subject, the respective frequencies of AR bin1 and AR bin2 phenotypes were equal to 39 and 43% (44% in males for either phenotype and 34 and 41% in females for AR bin1 and AR bin2 , respectively), while 52% of the siblings were asthmatic (Table 1 ). There was a strong relationship of AR bin1 and AR bin2 with asthma (Po0.0001) with a large part of sibs with AR having also asthma (82% for AR bin1 and 74% for AR bin2 ) compared to a proportion of 36 and 39% of asthmatic among the sibs without AR bin1 and AR bin2 , respectively ( Table 2 . To provide a summary indicator of the amount of information available for analysis of each phenotype, the numbers of independent sib-pairs deduced from the sibship size distribution (a sibship of size n corresponds to (nÀ1) independent sib-pairs) are also given in Table 2 . In the subsample of 185 families with at most one asthmatic sib, these distributions are given for rhinitis phenotypes only.
Linkage analysis
Linkage analyses were performed for the following affection statuses: 1/asthma, 2/AR bin1 , 3/AR bin2 , 4/AR cat , 5/AR bin1 associated with asthma and 6/AR bin2 associated with asthma in the whole sample of 295 families and for the AR phenotypes only in the subset of 185 families. Peaks of lod MLB scores leading to a P-value p0.005 are shown in Tables 3 (whole sample) and 4 (subset). For the chromosomes including the regions meeting our selection criteria, the curves of lod MLB scores are presented in Figures 1 (whole sample) and 2 (subset). In the whole sample of 295 families (Table 3) , three regions lead to a score lod MLBX1.96 (Pp10 À3 ): 1p31 for AR bin2 plus asthma (P ¼ 0.00016 at the D1S2890 marker), this region being also potentially linked but less significantly to either AR bin2 (P ¼ 0.005) or asthma (P ¼ 0.005) at D1S2797, which is 11 centimorgan (cM) apart from D1S2890; 2q32 for AR bin2 alone (P ¼ 0.00016) and 3p24-p14 for AR cat alone (P ¼ 0.001). Two other regions were also detected with a less stringent criterion (Pp0.005): 11p14 for AR bin1 (P ¼ 0.003) and 13q32 for AR bin2 (P ¼ 0.002). For asthma, only one region, 1p31, was detected with a P-value p0.005, this region being also linked to AR. Indeed, no region was detected for asthma alone, that is, without being also linked to one of the rhinitis phenotypes.
In the subsample of 185 families without asthmatic sibpairs (Table 4) , two other regions were detected with a P-value p0.001 for AR bin1 alone: 9p22 (P ¼ 0.001) and 9q22-q34 (P ¼ 0.0007). The 2q32 and 3p24-p14 regions, detected in the whole sample, also showed indication of linkage (P ¼ 0.005) in this subsample.
As seen from Figures 1 and 2, AR cat showed different linkage patterns from those obtained with AR bin1 and AR bin2 for all chromosomes, while peaks of lod MLB scores for AR bin1 and AR bin2 were observed at the same position (although at different levels) for chromosomes 1p, 2q and 11p. Interestingly, when adding asthma to AR in the definition of the affection status, only lod MLB scores in the 1p31 region are increased while there is a decrease in lod MLB scores in all other regions.
Discussion
Although asthma and AR are strongly correlated and have some common biological components including the atopic response, they also differ in many respects such as target organs that present substantial differences (there are no smooth muscles in the upper airways) and variations in their geographical distribution and epidemiological associations. 19 This leads to assume the existence of both common genetic components and specific factors for AR and asthma. The present genome screen showed potential linkage for AR and/or asthma (Pp0.001) to five regions: three regions being detected in the whole sample (1p31 more significantly for AR bin2 plus asthma than for AR bin2 or asthma alone, 2q32 for AR bin2 and 3p24-p14 for AR cat while two other regions were revealed in the subset of 185 families with at most one asthmatic sib for AR bin1 only (9q22-q34 and 9p22). Indication of linkage (Pp0.005) was observed in two additional regions in the whole sample: 11p14 for AR bin1 and 13q for AR bin2 . No region was found linked to asthma without being also linked to AR. Heterogeneity of results for the different rhinitis definitions, according to whether they are based on diagnosis or presence of symptoms, could be due to the difference of sample sizes used for each phenotype and/or to the type of information brought by each one. Moreover, power of linkage analysis for each type of phenotypes may depend on the underlying genetic model.
Note that we used here quite stringent thresholds (Pp0.001 or 0.005) to select linked regions, because of the increase of type one error due to multiple testing. None of our results reached the genome-wide significant level (Pp2 Â 10
À5
) proposed by Lander and Kruglyack, 20 although results of the two regions (1p31 and 2q32) reached the criteria of suggestive linkage (Pp7 Â 10
À4
). 20 However, the criteria proposed by Lander and Kruglyack 20 apply to very dense mapping and if the mapping is less dense (as it is the case here), these criteria become conservative. We then conducted whole-genome simulations to get genome-wide P-values, 21 which were p0.05 in two regions, 1p31 for AR bin2 plus asthma and 2q32 for AR bin2 supporting the evidence of linkage to these regions. In contrast, genome-wide P-values were greater than 0.05 for the three (or five) other selected regions showing a pointwise P-values p0.001 (or 0.005). Thus, only indication of linkage can be suggested for these latter regions. Note that most published genome scans did not report genome-wide P-values and the published pointwise P-values were, in most instances, of the same order of magnitude as those obtained in the present study. However, accumulating indication for linkage across studies may be more important than unreplicated high linkage peaks to identify regions of interest.
The present study is the third published genome scan of AR after one screen conducted in a Danish sample 12 and another one in a Japanese one. 13 The 9q22-q34 region detected for potential linkage to AR in our sample was also reported in the Japanese scan. 13 The linkage peak in the 2q32 region observed here for AR is about 40 cM apart from the linked region indicated in the Danish scan. 12 The other regions, 1p36 and 4q13, detected in the Japanese genome scan and 4q24-27 detected in the Danish screen were not replicated here. Lack of replication between the results of the French, Danish and the Japanese studies may be explained by either statistical issues (spurious detection of linkage, due to multiple tests, and/or lack of power) or by the heterogeneity between samples in terms of the phenotype definition (based only on questionnaire in the EGEA and Japanese studies and based on both questionnaire and clinical examination in the Danish study) and/or by the mode of ascertainment of the families. Moreover, the definition of rhinitis in Japanese and Danish studies included the presence of atopy defined either by RAST or SPT test. We then repeated all linkage analyses of AR by including a positive SPT for at least one allergen in the affection status definition. However, this led to unchanged results (results not shown) or to less significant results than for AR or AR plus asthma phenotypes not taking into account atopy. The ascertainment was performed through subjects with clinical atopy in the Danish study, through two children with orchard grass-sensitive rhinitis in the Japanese study and through asthmatic subjects in the EGEA sample. Thus, these differences in the modes of ascertainment of these samples might explain the different of results. Note that the mode of ascertainment of the French data had the advantage to allow examination of the shared and unshared linked chromosomal regions by asthma and AR.
In contrast, most of the regions detected in the present study were previously reported for asthma and/or related phenotypes by other genome scans which did not consider the AR phenotype and were applied to family samples mostly ascertained through asthmatics as in our study. Indeed, the 1p31 region has been already reported for linkage to asthma in the Caucasian population of the CSGA study, 22 to atopy 23 and IgE 24 in the Hispanic group of the same study and to IgE in a Dutch population. 25 The 2q32 region was previously detected for IgE in the two German 26 and Dutch 25 genome scans. It was also found to be linked to IgE in our sample but less significantly than to rhinitis and neither to skin prick test responses nor to other atopy-related phenotypes. 16 The linkage peak observed here for AR is around 15 cM apart from the CTLA-4 gene (cytotoxic T lymphocyte antigen 4), a gene that has been shown to be associated with IgE levels, 27 atopy and asthma. 28 Thus, detection of linkage in our study could correspond to the influence of this gene. Further fine mapping of these data will permit to confirm this point. The 3p24-p14 region has been reported for atopic dermatitis in a Swedish population, 29 asthma and BHR in the Hutterite population 14, 30 and mite sensitivity in the CSGA families. 31 The 9q22-q34 region has been reported for asthma in the Hutterites, for IgE and atopy in the German scan 25 and the region 11p14 for SPT and IgE in the Hutterite population, 14, 32 in the first EGEA scan 15 and in the German scan. 25 Finally, the last region detected here for rhinitis, 13q32-qter, has been already reported for asthma in the CSGA sample 22 and for Dermatophagoides pteronyssinus-specific IgE responsiveness 23 in Caucasian CSGA subjects. This region is adjacent to the 13q31 region detected for eosinophil counts in our sample. 15, 16 Results of the present study support evidence of linkage to AR and/or asthma for two regions 1p31 and 2q32 and suggest indication of linkage to 3p24-p14, 9p22, 9q22-q34 11p14 and 13q32 regions. These results do not indicate any linkage specific to asthma. They suggest that 1p31 may contain a genetic factor common to asthma and AR while the other regions are more likely to harbor genetic factors specific to AR. Since there is no indication of linkage of the 1p31 region to atopy-related phenotypes in our sample (total IgE, SPT, specific IgE), 16 this result is likely not due to the common allergic component of asthma and rhinitis. This is supported by a recent population-based study, which showed that the strong association between asthma and rhinitis was not fully explained by atopy. 33 A hypothesis already proposed at a physio-pathologic level is that asthma and rhinitis are different expressions of the same disease, thus the factor located on 1p31 may be involved in the different manifestations of the disease. Another proposed hypothesis is that asthma associated with AR corresponds to a severe form of the same disease; detection of linkage to 1p31 would correspond to a genetic factor involved in this severe form. Since there was no or only a weak indication of linkage of this region to AR in the 185 families without asthmatic sib-pairs (P ¼ 1.0) and to asthma after excluding the sib-pairs with rhinitis (P ¼ 0.06), the second hypothesis appears more likely than the first one. Further family studies of asthma and AR may be of interest to validate our findings.
Material and methods
Family data
The main EGEA sample included 348 nuclear families selected through one asthmatic proband. An additional sample of 40 nuclear families was selected directly through two asthmatic sibs in order to increase the number of informative families for linkage analyses of asthma. Inclusion criteria met by probands were described elsewhere. 34 As compared to our first genome scan conducted in a subsample of 107 EGEA families having at least two asthmatic sibs with DNA available, 15 the present scan was extended to 307 EGEA families with at least two sibs with DNA available. After excluding families with insufficient DNA available or showing non-Mendelian transmission, the analyzed sample consisted of 295 families including 1317 individuals. Ethical committee approved the protocol and subjects signed informed consent forms.
Phenotypes analyzed
Information on respiratory and allergic symptoms, medical history and environmental factors was collected with a standardized questionnaire. 35 Different clinical tests were performed, which were already described, 15 and bronchial responsiveness was included, which was measured using a protocol described in detail elsewhere. 34 All analyzed phenotypes were based on questionnaire and complementary test information.
Asthma phenotype was defined as used for the selection of the 107 families of the first genome scan, 15 with the following criteria: a positive response to at least one of the two questions ((1) Have you ever had attacks of breathlessness at rest with wheezing? (2) Have you ever had an asthma attack?) associated with either the presence of BHR (defined as a fall in baseline FEV 1 , the forced expiratory volume at one second, X20% at p4 mg/ml methacholine), an increase of baseline FEV 1 X12% after bronchodilator use, hospitalization for asthma in life or asthma therapy. 34 Three definitions of AR were considered, all based on questionnaire information. The first was a binary trait based on diagnosis: a positive answer to at least one of the two questions ( (1) Have you ever had AR? or (2) Have you ever had hay fever?) (AR bin1 ). The second binary trait was defined by the presence of at least one of the following symptoms: sneezing or runny nose to hay/flower or animals or dust (AR bin2 ). The third one was derived from the SFAR, which is based on these various items:
nasal symptoms in the past year including sneezing, runny nose and blocked nose when the subject did not have a cold or the 'flu' in the past year. nasal symptoms accompanied by itchy-watery eyes (rhinoconjonctivitis). months of the year in which nasal symptoms occurred. triggers of nasal symptoms including pollens, house dust mites, moulds and epithelia. allergic status assessed by a positive answer to the question 'have you ever been desensitized for allergy in your life?' previous medical diagnosis of hay fever.
The SFAR is a quantitative score previously validated using doctor's diagnosis of rhinitis and skin prick test positivity as gold standard. 17 The SFAR was shown to be highly correlated with objective markers of immediate hypersensitivity such as specific IgE and skin prick test positivity. 34 For the purpose of the present genetic study, familial resemblance of rhinitis was not introduced in the computation of the score.
Genotypes
A total of 1317 subjects were genotyped with a panel of 396 microsatellites (378 autosomal markers). The Linkage Marker Set MD 10 (Applied Biosystems, Foster City, CA, USA) formed the core marker set for the genome-wide screen. These microsatellite markers, labelled with fluorescent dyes (FAMt, HEXt, NEDt), are distributed at an average marker density of 10 cM (roughly every 10 million bases in the genome) and have an average heterozygosity of 75%. CNG (Centre National de Génotypage) has developed a protocol allowing the coamplification of up to six of these markers in a single reaction to be robust using dual 384-well GeneAmp s PCR 9700 cyclers (Applied Biosytems) and an automated procedure for PCR and purification setup. Automatic genotyping was performed based on a series of software processes implemented in Genetic Profiler software (version 1.1).
Before statistical analysis, rigorous genotype quality assurance was performed to ensure accurate binding of alleles. Consistency of the data with Mendelian inheritance and lack of double recombination between loci was evaluated using Pedcheck 36 and other purpose-written software.
Linkage analysis methods
Linkage analyses were performed by a model-free approach, the MLB method which can be applied to the whole sib-ship of affected subjects. 18, 37, 38 In brief, the principle of this method is based on the binomial distribution of the number of affected sibs receiving a given parental allele from heterozygous parents. The probability a for an affected sib to receive from his/her parent the marker allele transmitted with the disease allele is equal to 0.5 under the null hypothesis of no linkage and a is less than 0.5 under the hypothesis of linkage. Test for linkage is performed using a likelihood ratio test statistic, L ¼ 2Ln[L(a)/L(a ¼ 0.5)] with the statistic L being distributed asymptotically as a mixture distribution of 0.5 w This method, which has been extended to categorical traits, 39 is basically the same as the one proposed for binary traits, with the introduction of a latent binary variable capturing the linkage information between the observed categorical trait and the marker.
As a large proportion (0.34) of individuals had an SFAR score equal to 0, the score derived from SFAR could not be analyzed as a quantitative trait in linkage analysis, but as an ordered categorical traits (AR cat ) by the MLB method. Seven categories were considered and individuals were classified according to their score being equal to 0, 1, (2 or 3), (4 or 5), (6 or 7), 8 or (9 or greater) respectively. The choice of these classes was motivated by sample sizes within each class.
All linkage analyses were conducted using the program MLBGH, 40 which incorporates the MLB method into the multipoint approach of Genehunter. 41 These analyses were first conducted in the whole sample of 295 families (see family data section) and then, for the three AR phenotypes, in a subsample of 185 families in which all families with at least two asthmatic sibs were excluded. This latter sample was considered to distinguish between the regions linked specifically to AR from those linked to asthma, provided, in the whole sample, most AR sibpairs were also asthmatic sibpairs.
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